Dana-Farber Cancer Institute Dana-Farber Cancer Institute

Boston, Massachusetts 02215

0 studies enrolling now · 2 studies all time

What they study most

Advanced Solid Tumors, Hodgkin's Lymphoma

Studies at this site

• A Study of BLZ945 Single Agent or BLZ945 in Combination With PDR001 in Advanced Solid Tumors — Stopped early
• A Phase III Randomized, Double Blind, Placebo Controlled Multi-center Study of Panobinostat for Maintenance of Response in Patients With Hodgkin's Lymphoma (HL) — Completed